Jul. 11 at 2:40 PM
$SLS important to Note: this Nice little run, happened, SINCE the Independent Data Monitoring Committee UNBLINDED Actual Phase 3 Overall Survival and Immune Response Data.
- Actual Unblinded Phase 3 Data that Confirms GPs is Doing what it's done in 7 all Previous trials - Prevent Relapse and Extend Survival, including 2 AML Phase 2 CR trials.
-
$ABBV $BMY own Ven and Aza, BAT for Control Arm patients, and Know Precisely how their drugs Perform.
-- Link to Trial Data Showing OS of 8 months for AML Cr2 Patients, on Aza Ven - BAT for control - its 8 months, just like the 3 Dr's treating actual patients have stated.
Control arm Os is 8 months.
Unblinded Phase 3 data: All pooled P3 patients, Control (Aza Ven) + Gps patients had a NOT YET MET OS > Greater than 13.5 months at Interim.
Simple Math: Gps P3 patient mOS is a Not yet Met, Greater than > 19 months, in line with the Statistically Significant P2 results - 21 months.
> 19 at a median Follow Up of 13.5 months
https://www.reddit.com/r/sellaslifesciences/comments/1i8htb7/book_it_its_a_done_deal_gps_is_100_for_sure/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button
